Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|December 12, 2013
[The ideal of establishing an evaluation system about the combination program of Chinese medical pharmacy and western medical pharmacy]Yun-song Yang
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|January 30, 2019
[Overview and Future Thinking of Integrative Medicine]Yun-Song Yang
Biochemical and Biophysical Research Communications|December 17, 2013
GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell lineDong-dong Cheng, Hai-guang Zhao, Yun-song Yang, et al.
Translational Cancer Research|February 4, 2022
Prognostic value of primary tumor surgery in de novo stage IV breast cancer patients with different metastatic burdens: a propensity score-matched and population-based studyYun-Song Yang, Ying-Le Chen, Gen-Hong Di, et al.
Cancer Research|May 2, 2023
Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast CancerWen-Ting Peng, Xi Jin, Xiao-En Xu, et al.
Oncogene|March 3, 2021
Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitorLi-Ping Ge, Xi Jin, Yun-Song Yang, et al.
Oncogene|January 28, 2026
TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancerWen-Ya Wu, Yun-Song Yang, Lisa Andriani, et al.
Breast Cancer Research and Treatment|March 25, 2022
The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic targetYun-Song Yang, Yi-Xing Ren, Cheng-Lin Liu, et al.
Cell Discovery|November 10, 2025
Landscape of gene fusions in hormone receptor-positive breast cancer reveals ADK fusions as drivers of progression and potential therapeutic targetsYang Ou-Yang, Ding Ma, Cai-Jin Lin, et al.
Clinical and Translational Medicine|November 29, 2021
Large-scale genomic sequencing reveals adaptive opportunity of targeting mutated-PI3Kα in early and advanced HER2-positive breast cancerLin-Wei Guo, Xiao-Guang Li, Yun-Song Yang, et al.
Pageof 3